1
|
Du Y, Pan T, Zhong X, Liu N, Zhang Q. Predictive value of thyroid-stimulating hormone in postmenopausal type 2 diabetes mellitus patients with normal thyroid function associated with ultrasound-diagnosed non-alcoholic fatty liver disease. ALL LIFE 2022. [DOI: 10.1080/26895293.2022.2035827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
Affiliation(s)
- Yijun Du
- Department of Endocrinology, The First Hospital of Anhui Medical University, Hefei, China
- Department of Endocrinology, The Second Hospital of Anhui Medical University, Hefei, China
| | - Tianrong Pan
- Department of Endocrinology, The Second Hospital of Anhui Medical University, Hefei, China
| | - Xing Zhong
- Department of Endocrinology, The Second Hospital of Anhui Medical University, Hefei, China
| | - Nina Liu
- Department of Endocrinology, The Second Hospital of Anhui Medical University, Hefei, China
| | - Qiu Zhang
- Department of Endocrinology, The First Hospital of Anhui Medical University, Hefei, China
| |
Collapse
|
2
|
Du YJ, Liu NN, Zhong X, Pan TR. Risk Factors for Nonalcoholic Fatty Liver Disease in Postmenopausal Women with Type 2 Diabetes Mellitus and the Correlation with Bone Mineral Density at Different Locations. Diabetes Metab Syndr Obes 2022; 15:1925-1934. [PMID: 35761888 PMCID: PMC9233539 DOI: 10.2147/dmso.s364804] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Accepted: 05/31/2022] [Indexed: 12/25/2022] Open
Abstract
OBJECTIVE To explore the risk factors for nonalcoholic fatty liver disease (NAFLD) in postmenopausal women with type 2 diabetes mellitus (T2DM) and the correlation with bone mineral density (BMD) in different areas of the body. METHODS A total of 434 postmenopausal women with T2DM were enrolled and categorized as 198 patients in the NAFLD group and 236 patients in the non-NAFLD group based on color Doppler ultrasound of the liver. The BMD of the lumbar spine, femoral neck, and total hip were measured by dual-energy X-ray absorptiometry. RESULTS In postmenopausal women with T2DM, the prevalence of NAFLD was 45.6%. The body mass index (BMI), systolic blood pressure (SBP), glycosylated hemoglobin (HbA1c), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGT), triacylglycerol (TG), uric acid (UA), and homeostatic model assessment for insulin resistance (HOMA-IR) C-peptide (CP) were significantly higher in the NAFLD group than in the non-NFALD group, and the duration of diabetes, and high-density lipoprotein cholesterol (HDL-C) were lower than in the non-NAFLD group (P < 0.05). Logistic regression analysis revealed that BMI (odds ratio [OR] = 1.303, 95% confidence interval [CI]: 1.152-1.346), HbA1c (OR = 1.263, 95% CI: 1.095-1.392), TG (OR = 1.263, 95% CI: 1.031-1.601), and SUA (OR = 1.005, 95% CI: 1.001-1.007) were correlated with NAFLD (P < 0.05). The BMD of the total hip and femoral neck in the NAFLD group was higher than in the non-NAFLD group (P < 0.05). CONCLUSION Complicated NAFLD in postmenopausal women with T2DM is associated with weight gain, poor blood glucose control, abnormal lipid metabolism, and elevated UA levels. In addition, the NAFLD group had higher femoral neck and total hip BMD than the non-NAFLD group, suggesting NAFLD in postmenopausal women with T2DM may reduce the risk of osteoporosis.
Collapse
Affiliation(s)
- Yi-Jun Du
- Department of Endocrinology, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of China
| | - Ni-Na Liu
- Department of Endocrinology, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of China
| | - Xing Zhong
- Department of Endocrinology, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of China
| | - Tian-Rong Pan
- Department of Endocrinology, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of China
- Correspondence: Tian-Rong Pan, Department of Endocrinology, The Second Hospital of Anhui Medical University, No. 678 of Furong Road, Jingkai District, Hefei, 230601, People’s Republic of China, Tel +86 15305609568, Email
| |
Collapse
|
3
|
Razin M, Abdel-Ghaffar ARB, Hamdy GM, Abd-Elshafy DN, Kamel S, Bahgat MM, Maghraby AS. TLR3\TLR7 as Differentially Expressed Markers Among Viral, Nonviral, and Autoimmune Diseases in Egyptian Patients. Viral Immunol 2021; 34:607-621. [PMID: 34342515 DOI: 10.1089/vim.2021.0006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Toll-like receptors (TLRs) represent the immune link between the innate and the adaptive immune signals against various pathogens. This study aimed to evaluate the TLRs3 and 7 as immune-markers in differentiating between hepatitis C virus (HCV)-infected and -uninfected patients. Also, the use of the TLR3 and TLR7 as immune markers was compared with the prevalent bio and immune markers for autoimmune diseases in HCV-infected or -uninfected patients. The levels of GPT, GOT, B cell activated factors, tumor necrosis factor-alpha (TNF-α), and interleukin (IL)-10 were measured in plasma, while the levels of TLR3 and TLR7 were quantified in lysates of peripheral blood mononuclear cells from healthy donors, HCV-infected patients, nonalcoholic fatty liver (NAFL) patients without autoimmune diseases and with autoimmune diseases (HCV-infected patients with autoimmune diseases [HCV+auto], nonalcoholic fatty liver patients with autoimmune diseases [NAFL+auto]), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) patients. The relative expression of TLR3, TLR7, TNF, and IL-10 in cell lysates was assessed against glyceraldehyde 3-phosphate dehydrogenase (GAPDH) by quantitative real time-polymerase chain reaction (qRT-PCR). Results showed that TLRs 3 and 7 levels were significantly higher in SLE, RA, HCV, HCV+auto, and the NAFL patients compared to the normal control. The cell lysates from SLE patients expressed TLR3 at relatively significantly higher mRNA levels compared to normal subjects or other patient groups. The NAFL+auto patients expressed TLR7 at relatively significantly high mRNA levels compared to normal subjects or other patients. The RA patients expressed TLR7 at relatively significantly higher mRNA levels when compared to HCV, HCV+auto, and NAFL+auto patients. Conclusions: At the protein level, TLR7 can differentiate between HCV and NAFL patients. In addition, both TLRs3 and 7 can serve as potent markers in differentiating between NAFL and NAFL+auto.
Collapse
Affiliation(s)
- Mona Razin
- Division of Pharmaceutical and Drug Industries Research, Department of Therapeutic Chemistry, Cairo, Egypt.,Research Group Immune- and Bio-markers for Infection, the Centre of Excellence for Advanced Sciences, the National Research Centre, Cairo, Egypt
| | | | - Germine M Hamdy
- Biochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt
| | - Dina N Abd-Elshafy
- Research Group Immune- and Bio-markers for Infection, the Centre of Excellence for Advanced Sciences, the National Research Centre, Cairo, Egypt.,Department of Water Pollution Research, the National Research Centre, Cairo, Egypt
| | - Solaf Kamel
- Department of Clinical and Chemical Pathology, the National Research Centre, Cairo, Egypt
| | - Mahmoud Mohamed Bahgat
- Division of Pharmaceutical and Drug Industries Research, Department of Therapeutic Chemistry, Cairo, Egypt.,Research Group Immune- and Bio-markers for Infection, the Centre of Excellence for Advanced Sciences, the National Research Centre, Cairo, Egypt
| | - Amany Sayed Maghraby
- Division of Pharmaceutical and Drug Industries Research, Department of Therapeutic Chemistry, Cairo, Egypt.,Research Group Immune- and Bio-markers for Infection, the Centre of Excellence for Advanced Sciences, the National Research Centre, Cairo, Egypt
| |
Collapse
|
4
|
Consumption of barley ameliorates the diabetic steatohepatitis and reduces the high transforming growth factor β expression in mice grown in α-minimum essential medium in vitro as embryos. Biochem Biophys Rep 2021; 27:101029. [PMID: 34136664 PMCID: PMC8181192 DOI: 10.1016/j.bbrep.2021.101029] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Revised: 05/06/2021] [Accepted: 05/17/2021] [Indexed: 12/12/2022] Open
Abstract
Non-alcoholic fatty liver disease (NAFLD), which includes the subtype non-alcoholic steatohepatitis (NASH), is a major complication of type 2 diabetic mellitus (T2DM), even among non-obese patients. However, the exact cause of NAFLD/NASH in non-obese patients with T2DM is unclear. We studied a non-obese mouse model of T2DM created through the malnourishment of embryos by culture in vitro for 48 h in α-minimum essential medium (MEM) at the two-cell stage. We compared the development of steatohepatitis in these MEM mice with control mice that were similarly cultured in standard potassium simplex-optimized medium (KSOM). We also studied the effects of 10 weeks of consumption of barley, which contains large amounts of the soluble fiber β-glucan, on the steatohepatitis of the adult MEM mice. The size of lipid droplets, the area of fibrosis, and the mRNA expression of the transforming growth factor beta (Tgfb) gene in the liver were higher in adult MEM mice fed a rice-based diet than in KSOM mice fed the same diet. However, barley consumption reduced the area of fibrosis and TGFB expression in MEM mice. In conclusion, adult mice that are cultured in MEM at the two-cell embryo stage develop steatohepatitis and T2DM, accompanied by higher hepatic TGFB expression, than KSOM controls. Furthermore, the consumption of barley during adulthood ameliorates the steatohepatitis and reduces the TGFB expression. The mouse preimplantation embryos cultured in αMEM in vitro developed steatohepatitis. Dietary barley suppressed diabetic steatohepatitis with fibrosis. Barley intake also reduced gene and protein expression of TGFB in livers of MEM mice.
Collapse
|
5
|
Noninvasive biomarkers predict improvement in liver fibrosis after successful generic DAAs based therapy of chronic hepatitis C in Egypt. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH 2020. [DOI: 10.1016/j.cegh.2020.04.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
|
6
|
El Saeed KM, Ahmed OA, Khalifa MO, Fahmy EM. Detection of patatin-like phospholipase domain-containing protein 3 in nonalcoholic fatty liver disease among egyptian patients. THE EGYPTIAN JOURNAL OF INTERNAL MEDICINE 2019. [DOI: 10.4103/ejim.ejim_43_18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
7
|
Zhao J, Wang Y, Wu X, Tong P, Yue Y, Gao S, Huang D, Huang J. Inhibition of CCL19 benefits non‑alcoholic fatty liver disease by inhibiting TLR4/NF‑κB‑p65 signaling. Mol Med Rep 2018; 18:4635-4642. [PMID: 30221732 DOI: 10.3892/mmr.2018.9490] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2018] [Accepted: 08/21/2018] [Indexed: 11/06/2022] Open
Abstract
Non‑alcoholic fatty liver disease (NAFLD), which affects approximately one‑third of the general population, has become a global health problem. Thus, more effective treatments for NAFLD are urgently required. In the present study, high levels of C‑C motif ligand 19 (CCL19), signaling pathways such as Toll‑like receptor 4 (TLR4)/nuclear factor‑κB (NF‑κB), and proinflammatory factors including interleukin‑6 (IL‑6) and tumor necrosis factor‑α (TNF‑α) were detected in NAFLD patients, thereby indicating that there may be an association between CCL19 and these factors in NAFLD progression. Using a high‑fat diet (HFD), the present study generated a Sprague‑Dawley rat model of NAFLD, which displayed dyslipidemia with increased levels of plasma aspartate aminotransferase, alanine aminotransferase, total cholesterol and triglyceride. Dyslipidemia, liver histopathology and gene expression analyses indicated that the NAFLD model was successfully induced by HFD, and metformin and berberine (BBR) were effective treatments for NAFLD. HFD‑induced CCL19 levels and associated factors were markedly reduced by the two drug treatments. In addition, metformin or BBR alone significantly promoted adenosine monophosphate‑activated protein kinase (AMPK) phosphorylation, which was inhibited by HFD. These results demonstrated that metformin and BBR could improve NAFLD, which may be via the activation of AMPK signaling, and the high expression of CCL19 in NAFLD was significantly reduced by metformin and BBR. It could be inferred that inhibition of CCL19 may be an effective treatment for NAFLD.
Collapse
Affiliation(s)
- Jiajing Zhao
- Department of Traditional Chinese Medicine, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China
| | - Yingjue Wang
- Department of Traditional Chinese Medicine, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China
| | - Xi Wu
- Department of Endocrinology, Huashan Hospital, Fu Dan University, Shanghai 200040, P.R. China
| | - Ping Tong
- Department of Endocrinology, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China
| | - Yaohan Yue
- Department of Traditional Chinese Medicine, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China
| | - Shurong Gao
- Department of Traditional Chinese Medicine, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China
| | - Dongping Huang
- Department of General Surgery, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China
| | - Jianwei Huang
- Department of General Surgery, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China
| |
Collapse
|